Genetic susceptibility to childhood leukaemia

Radiation Protection Dosimetry

Volumn 132, Issue 2, 2008, Pages 119-129

  Chokkalingam, Anand P ^a   Buffler, Patricia A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CALIFORNIA; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LEUKEMIA; MALE;

EID: 58549100295     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncn255     Document Type: Article

References (77)

1. Greaves, M. F. and Alexander, F. An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 7, 349-360 (1993).
2. Buffler, P. A., Kwan, M. L., Reynolds, P. and Urayama, K. Y. Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest. 23, 60-75 (2005).
3. Greaves, M. F., Maia, A. T., Wiemels, J. L. and Ford, A. M. Leukemia in twins: Lessons in natural history. Blood 102, 2321-2333 (2003).
4. Hunter, D. J. Gene-environment interactions in human diseases. Nat. Rev. Genet. 6, 287-298 (2005).
5. Mori, H., Colman, S. M., Xiao, Z., Ford, A. M., Healy, L. E., Donaldson, C., Hows, J. M., Navarrete, C. and Greaves, M. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. USA 99, 8242-8247 (2002).
6. Andreasson, P., Schwaller, J., Anastasiadou, E., Aster, J. and Gilliland, D. G. The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet. Cytogenet. 130, 93-104 (2001).
7. Greaves, M. Aetiology of acute leukaemia. Lancet 349, 344-349 (1997).
8. Pereira, T. V., Rudnicki, M., Pereira, A. C., Pombo-de-Oliveira, M. S. and Franco, R. F. 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: A meta-analysis. Cancer Epidemiol. Biomarkers Prev. 15, 1956-1963 (2006).
9. Ye, Z. and Song, H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: A systematic review and meta-analysis. Eur. J. Cancer 41, 980-989 (2005).
10. Xiao, Z., Greaves, M. F., Buffler, P., Smith, M. T., Segal, M. R., Dicks, B. M., Wiencke, J. K. and Wiemels, J. L. Molecular characterization of genomic AML1-ETO fusions in childhood leukemia. Leukemia 15, 1906-1913 (2001).
11. Blount, B. C., Mack, M. M., Wehr, C. M., MacGregor, J. T., Hiatt, R. A., Wang, G., Wickramasinghe, S. N., Everson, R. B. and Ames, B. N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA 94, 3290-3295 (1997).
12. Thompson, J. R., Gerald, P. F., Willoughby, M. L. and Armstrong, B. K. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: A case-control study. Lancet 358, 1935-1940 (2001).
13. Pui, C. H., Relling, M. V. and Downing, J. R. Acute lymphoblastic leukemia. N. Engl. J. Med. 350, 1535-1548 (2004).
14. Franco, R. F., Simoes, B. P., Tone, L. G., Gabellini, S. M., Zago, M. A. and Falcao, R. P. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia Br. J. Haematol. 115, 616-618 (2001).
15. Balta, G., Yuksek, N., Ozyurek, E., Ertem, U., Hicsonmez, G., Altay, C. and Gurgey, A. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYPIA1 genotypes in childhood acute leukemia. Am. J. Hematol. 73 154-160 (2003).
16. Chiusolo, P. et al. Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population. Haematologica 89, 139-144 (2004).
17. Krajinovic, M., Lamothe, S., Labuda, D., Lemieux-Blanchard, E., Theoret, Y., Moghrabi, A. and Sinnett, D. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 103, 252-257 (2004).
18. Chatzidakis, K., Goulas, A., Athanassiadou-Piperopoulou, F., Fidani, L., Koliouskas, D. and Mirtsou, V. Methylenetetrahydrofolate reductase C677T polymorphism: Association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in Greek patients. Pediatr. Blood Cancer 47, 147-151 (2006).
19. Oliveira, E., Alves, S., Quental, S., Ferreira, F., Norton, L., Costa, V., Amorim, A. and Prata, M. J. The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J. Pediatr. Hematol. Oncol. 27, 425-429 (2005).
20. Schnakenberg, E., Mehles, A., Cario, G., Rehe, K., Seidemann, K., Schlegelberger, B., Elsner, H. A., Welte, K. H., Schrappe, M. and Stanulla, M. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med. Genet. 6, 23 (2005).
21. Thirumaran, R. K., Gast, A., Flohr, T., Burwinkel, B., Bartram, C., Hemminki, K. and Kumar, R. MTHFR genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Blood 106, 2590-2591; author reply 2591-2592 (2005).
22. Zanrosso, C. W., Hatagima, A., Emerenciano, M., Ramos, F., Figueiredo, A., Felix, T. M., Segal, S. L., Guigliani, R., Muniz, M. T. and Pombo-de-Oliveira, M. S. The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leuk. Res. 30, 477-481 (2006).
23. Giovannetti, E., Ugrasena, D. G., Supriyadi, E., Vroling, L., Azzarello, A., de Lange, D., Peters, G. J., Veerman, A. J. and Cloos, J. Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia. Leuk. Res. 32, 19-24 (2007).
24. Reddy, H. and Jamil, K. Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk. Lymphoma 47, 1333-1339 (2006).
25. Kim, N. K., Chong, S. Y., Jang, M. J., Hong, S. H., Kim, H. S., Cho, E. K., Lee, J. A., Ahn, M. J., Kim, C. S. and Oh, D. Association of the methylenetetrahydrofolate reductase polymorphism in Korean patients with childhood acute lymphoblastic leukemia. Anticancer Res. 26, 2879-2881 (2006).
26. Petra, B. G., Janez, J. and Vita, D. Gene-gene interactions in the folate metabolic pathway influence the risk for acute lymphoblastic leukemia in children. Leuk. Lymphoma 48, 786-792 (2007).
27. Strange, R. C. and Fryer, A. A. The glutathione S-transferases: influence of polymorphism on cancer susceptibility. IARC Sci. Publ. 148, 231-249 (1999).
28. Brockmoller, J., Cascorbi, I., Henning, S., Meisel, C. and Roots, I. Molecular genetics of cancer susceptibility. Pharmacology 61, 212-227 (2000).
29. Coles, B. F. and Kadlubar, F. F. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: Determinants of individual response to chemical carcinogens and chemotherapeutic drugs? Biofactors 17, 115-130 (2003).
30. Krajinovic, M., Labuda, D., Richer, C., Karimi, S. and Sinnett, D. Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 93 1496-1501 (1999).
31. Saadat, I. and Saadat, M. The glutathione S-transferase mu polymorphism and susceptibility to acute lymphocytic leukemia. Cancer Lett. 158, 43-45 (2000).
32. Alves, S., Amorim, A., Ferreira, F., Norton, L. and Prata, M. J. The GSTM1 and GSTT1 genetic polymorphisms and susceptibility to acute lymphoblastic leukemia in children from north Portugal. Leukemia 16, 1565-1567 (2002).
33. Davies, S. M., Bhatia, S., Ross, J. A., Kiffmeyer, W. R., Gaynon, P. S., Radloff, G. A., Robison, L. L. and Perentesis, J. P. Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100, 67-71 (2002).
34. Barnette, P. et al. High-throughput detection of glutathione S-transferase polymorphic alleles in a pediatric cancer population. Cancer Epidemiol. Biomarkers Prev. 13, 304-313 (2004).
35. Canalle, R., Burim, R. V., Tone, L. G. and Takahashi, C. S. Genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukemia. Environ. Mol. Mutagen 43, 100-109 (2004).
36. Joseph, T., Kusumakumary, P., Chacko, P., Abraham, A. and Radhakrishna Pillai, M. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children Pediatr. Blood Cancer 43, 560-567 (2004).
37. Wang, J., Zhang, L., Feng, J., Wang, H., Zhu, S., Hu, Y. and Li, Y. Genetic polymorphisms analysis of glutathione S-transferase M1 and T1 in children with acute lymphoblastic leukemia. J. Huazhong Univ. Sci. Technolog. Med. Sci. 24, 243-244 (2004).
38. Zielinska, E., Zubowska, M. and Bodalski, J. Polymorphism within the glutathione S-transferase P1 gene is associated with increased susceptibility to childhood malignant diseases. Pediatr. Blood Cancer 43, 552-529 (2004).
39. Aydin-Sayitoglu, M., Hatirnaz, O., Erensoy, N. and Ozbek, U. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias. Am. J. Hematol. 81, 162-170 (2006).
40. Pakakasama, S., Mukda, E., Sasanakul, W., Kadegasem, P., Udomsubpayakul, U., Thithapandha, A. and Hongeng, S. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia. Am. J. Hematol. 79, 202-205 (2005).
41. Clavel, J. et al. Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur. J. Cancer Prev. 14, 531-540 (2005).
42. Krajinovic, M., Labuda, D. and Sinnett, D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics 12, 655-658 (2002).
43. Gatedee, J., Pakakassama, S., Muangman, S. and Pongstaporn, W. Glutathione S-transferase p1 genotypes, genetic susceptibility and outcome of therapy in Thai childhood acute lymphoblastic leukemia. Asian Pac. J. Cancer Prev. 8, 294-296 (2007).
44. Wiemels, J. L., Pagnamenta, A., Taylor, G. M., Eden, O. B., Alexander, F. E. and Greaves, M. F. A lack of a functional NAD(P) H: Quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res. 59, 4095-4099 (1999).
45. Krajinovic, M., Sinnett, H., Richer, C., Labuda, D. and Sinnett, D. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int. J. Cancer 97, 230-236 (2002).
46. Kracht, T. et al. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. Haematologica, 89, 1492-1497 (2004).
47. Sirma, S. et al. NAD(P) H:qUinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr. Blood Cancer 43, 568-570 (2004).
48. Eguchi-Ishimae, M., Eguchi, M., Ishii, E., Knight, D., Sadakane, Y., Isoyama, K., Yabe, H., Mizutani, S. and Greaves, M. The association of a distinctive allele of NAD(P) H:qUinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan Haematologica 90, 1511-1515 (2005).
49. Lanciotti, M. et al. Genetic polymorphism of NAD(P) H:qUinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements. Leukemia 19, 214-216 (2005).
50. Guha, N., Chang, J. S., Chokkalingam, A. P., Wiemels, J. L., Smith, M. T. and Buffler, P. A. NQO1 polymorphisms and de novo childhood leukemia: A HuGE review and meta-analysis. Am. J. Epidemiol. (2008) (in press).
51. Hattori, H., Suminoe, A., Wada, M., Koga, Y., Kohno, K., Okamura, J., Hara, T. and Matsuzaki, A. Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia. Leuk. Res. 31, 1633-1640 (2007).
52. Jamroziak, K., Mlynarski, W., Balcerczak, E., Mistygacz, M., Trelinska, J., Mirowski, M., Bodalski, J. and Robak, T. Functional C3435T polymorphism of MDR1 gene: An impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur. J. Haematol. 72, 314-321 (2004).
53. Urayama, K. Y., Wiencke, J. K., Buffler, P. A., Chokkalingam, A. P., Metayer, C. and Wiemels, J. L. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol. Biomarkers Prev. 16, 1172-1177 (2007).
54. Semsei, A. F. et al. Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leuk. Res. 32, 1214-1220 (2008).
55. Greaves, M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur. J. Cancer 35, 173-185 (1999).
56. Martin, A. M., Athanasiadis, G., Greshock, J. D., Fisher, J., Lux, M. P., Calzone, K., Rebbeck, T. R. and Weber, B. L. Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes. Hum. Hered. 55, 171-178 (2003).
57. Greaves, M. Infection, immune responses and the aetiology of childhood leukaemia. Nat. Rev. Cancer 6, 193-203 (2006).
58. Dorak, M. T., Owen, G., Galbraith, I., Henderson, N., Webb, D., Mills, K. I., Darke, C. and Burnett, A. K. Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia. Leukemia 9, 875-878 (1995).
59. Dearden, S. P. et al. Molecular analysis of HLA-DQB1 alleles in childhood common acute lymphoblastic leukaemia. Br. J. Cancer 73 603-609 (1996).
60. Taylor, G. M., Dearden, S., Payne, N., Ayres, M., Gokhale, D. A., Birch, J. M., Blair, V., Stevens, R. F., Will, A. M. and Eden, O. B. Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. Br. J. Cancer 78, 561-565 (1998).
61. Taylor, G. M., Dearden, S., Ravetto, P., Ayres, M., Watson, P., Hussain, A., Greaves, M., Alexander, F. and Eden, O. B. Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLA-DPB1*0201. Hum. Mol. Genet. 11, 1585-1597 (2002).
62. Carlson, C. S., Eberle, M. A., Rieder, M. J., Yi, Q., Kruglyak, L. and Nickerson, D. A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74, 106-120 (2004).
63. Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Science, 296, 2225-2229 (2002).
64. Hoggart, C. J., Shriver, M. D., Kittles, R. A., Clayton, D. G. and McKeigue, P. M. Design and analysis of admixture mapping studies. Am. J. Hum. Genet. 74, 965-978 (2004).
65. Falush, D., Stephens, M. and Pritchard, J. K. Inference of population structure using multilocus genotype data: Linked loci and correlated allele frequencies. Genetics 164, 1567-1587 (2003).
66. U.S. Cancer Statistics Working Group: United States Cancer Statistics 2002 Incidence and Mortality. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute (2005).
67. Terwilliger, J. D. and Ott, J. A novel polylocus method for linkage analysis using the lod-score or affected sib-pair method. Genet. Epidemiol. 10, 477-482 (1993).
68. Thomas, D. C. Statistical Methods in Genetic Epidemiology (New York, NY: Oxford University Press) (2004).
69. Collins-Schramm, H. E., Chima, B., Morii, T., Wah, K., Figueroa, Y., Criswell, L. A., Hanson, R. L., Knowler, W. C., Silva, G., Belmont, J. W. and Seldin, M. F. Mexican American ancestry-informative markers: examination of population structure and marker characteristics in European Americans, Mexican Americans, Amerindians and Asians. Hum. Genet. 114, 263-271 (2004).
70. Yang, N., Li, H., Criswell, L. A., Gregersen, P. K., Alarcon-Riquelme, M. E., Kittles, R., Shigeta, R., Silva, G., Patel, P. I., Belmont, J. W. and Seldin, M. F. Examination of ancestry and ethnic affiliation using highly informative diallelic DNA markers: Application to diverse and admixed populations and implications for clinical epidemiology and forensic medicine. Hum. Genet. 118, 382-392 (2005).
71. Groves, F., Auvinen, A. and Hakulinen, T. Haemophilus influenzae type b vaccination and risk of childhood leukemia in a vaccine trial in Finland. Ann. Epidemiol. 10, 474 (2000).
72. Mellemkjaer, L., Alexander, F. and Olsen, J. H. Cancer among children of parents with autoimmune diseases. Br. J. Cancer 82, 1353-1357 (2000).
73. Dickersin, K. The existence of publication bias and risk factors for its occurrence. JAMA 263, 1385-1389 (1990).
74. Milne, E., Laurvick, C. L., Blair, E., Bower, C. and de Klerk, N. Fetal growth and acute childhood leukemia: Looking beyond birth weight Am. J. Epidemiol. 166, 151-159 (2007).
75. Tower, R. L. and Spector, L. G. The epidemiology of childhood leukemia with a focus on birth weight and diet. Crit. Rev. Clin. Lab. Sci. 44, 203-242 (2007).
76. Witte, J. S. Multiple prostate cancer risk variants on 8q24. Nat. Genet. 39, 579-580 (2007).
77. Kraft, P. and Cox, D. G. Study designs for genome-wide association studies. Adv. Genet. 60, 465-504 (2008).